On Apr. 26, 2021, Moderna announced that it had entered into an agreement with Sanofi for fill/finish sterile manufacturing services and supply packaging for up to 200 million doses of the Moderna COVID-19 Vaccine in the U.S. beginning in September 2021.

Sanofi leveraged its established manufacturing infrastructure at its site in Ridgefield, NJ.